Hepatocyte nuclear factor‐1β is not a specific marker of clear cell carcinoma in serous effusions

Publisher： John Wiley & Sons Inc

E-ISSN： 1934-6638|122|2|153-158

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.122, Iss.2, 2014-02, pp. : 153-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased Transforming Growth Factor β1 Plasma Level in Patients with Renal Cell Carcinoma:A Tumor-Specific Marker?

By  

Urologia Internationalis, Vol. 60, Iss. 4, 1998-08 ,pp. : 205-207

Karger

Access to resources Recommend Favorite

The role of hepatocyte nuclear factor 1β in disease and development

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. S1, 2016-09 ,pp. : 23-32

John Wiley & Sons Inc

Access to resources Recommend Favorite

Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high‐grade serous carcinoma

By  

APMIS (ELECTRONIC), Vol. 126, Iss. 1, 2018-01 ,pp. : 45-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gadoxetic acid‐enhanced magnetic resonance imaging reflects co‐activation of β‐catenin and hepatocyte nuclear factor 4α in hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 2, 2018-02 ,pp. : 205-216

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulinoma‐associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma)

By  

JOURNAL OF CUTANEOUS PATHOLOGY, Vol. 45, Iss. 2, 2018-02 ,pp. : 129-135

John Wiley & Sons Inc

Access to resources Recommend Favorite